Well, historically, Don/RVX has always seemed to be able to come up with what it needs to continue forward. Despite disappointments, the company and apabetalone has come a long way, continually refining and defining along the way, inching toward "acceptance" ... it doesn't hurt to show they can still generate financial interest, and actually do so in reality to help with current needs. Negotiating and closing a favorable Option-1 is at least a tiny bit easier, if Option-2 and Option-3 appear doable. Hopefully, there are competitors for Option-1, as well, so no one BP can dictate the terms of a deal deal and force it on a cash strapped desperate RVX. 

BP's need to look at RVX for what the technology can do for their present, future, and R&D pipeline, as well as competitive postioning.

Not loving my view with Fuzz and everyone else here in the mushroom community of smaller investors, but excited about the possibilities, and looking forward to some material news developments sometime soon. glta